UnitedHealth Group Incorporated logo UNH - UnitedHealth Group Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 43
HOLD 5
SELL 4
STRONG
SELL 0
| PRICE TARGET: $431.88 DETAILS
HIGH: $492.00
LOW: $370.00
MEDIAN: $437.50
CONSENSUS: $431.88
UPSIDE: 0.50%

Stock News

UnitedHealthcare Launches New Spending Account Benefit, Putting More Choice in the Hands of Consumers

UnitedHealthcare Launches New Spending Account Benefit, Putting More Choice in the Hands of Consumers

--(BUSINESS WIRE)--UnitedHealthcare has introduced a Lifestyle Spending Account (LSA), an employer-sponsored benefit that gives companies a flexible way to help fund and support their employees' individual health and well-being goals. When offered by an employer, the LSA is designed to help empower people to personalize their experience and shop for products and services to complement their other employer-sponsored benefits at any time. UnitedHealthcare has integrated its LSA with UHC Store, a.

Jul 09, 2026 05:00 AM • businesswire.com
UnitedHealth: Patience Could Be Rewarded

UnitedHealth: Patience Could Be Rewarded

UnitedHealth Group remains undervalued and is positioned as a strong long-term investment despite recent price appreciation and operational challenges. Management maintains a long-term growth algorithm of 13–16% bottom-line growth, driven by margin recovery, AI investments, and capital allocation including share buybacks. Current valuation models, even with conservative growth assumptions, suggest significant intrinsic value upside, but recent rapid price gains may limit short-term upside.

Jul 03, 2026 11:34 PM • seekingalpha.com
UnitedHealth Group: The Turnaround Continues Into The Q2 Report

UnitedHealth Group: The Turnaround Continues Into The Q2 Report

UnitedHealth Group is reiterated as a buy, with a raised price target near $460, reflecting improved earnings guidance and operational turnaround. Q1 results beat expectations, with non-GAAP EPS of $7.23 and revenue of $111.7B, prompting an FY 2026 EPS outlook above $18.25 and a $2B buyback. UNH benefits from strong free cash flow, a 2.18% yield, positive EPS revisions, and strategic investments in modernization and AI.

Jul 02, 2026 10:54 AM • seekingalpha.com
UnitedHealth Group Now Covers Guardant Health's Shield Blood Test for Colorectal Cancer Screening

UnitedHealth Group Now Covers Guardant Health's Shield Blood Test for Colorectal Cancer Screening

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group (UHG) members1, making it the first major commercial insurer to provide coverage for adults 45 or older amid rising CRC rates for adults under 652 and mortality for younger adults as the leading cause of cancer death for those under 50.3 Shield is the first and onl.

Jul 01, 2026 10:50 AM • businesswire.com

Price Targets